Vimian Group AB (VIMGF) Stock Price, Trades & News

Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	0.2
Equity-to-Asset	0.62
Debt-to-Equity	0.34
Debt-to-EBITDA	2.2
Interest Coverage	4.39
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.86	Distress Grey Safe
Beneish M-Score	-2.84	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

8/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	5.8
	3-Year EBITDA Growth Rate	27.9
	3-Year EPS without NRI Growth Rate	13.1
	3-Year FCF Growth Rate	67.9
	3-Year Book Growth Rate	7.5
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	21.89
	Future 3-5Y Total Revenue Growth Rate Estimate	9.9

Momentum Rank

3/10

	Name	Current	Vs Industry		Vs History
	14-Day RSI	0.05
	12-1 Month Momentum %	-30.58

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.71
	Quick Ratio	1.04
	Cash Ratio	0.38
	Days Inventory	221.18
	Days Sales Outstanding	50.9
	Days Payable	61.43

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-5
	Shareholder Yield %	-3.03

Profitability Rank

5/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	69
	Operating Margin %	16.69
	Net Margin %	8.46
	EBITDA Margin %	25.7
	FCF Margin %	21.45
	OCF Margin %	25.79
	ROE %	5.27
	ROA %	3.26
	ROIC %	4.97
	ROC (Joel Greenblatt) %	83.16
	ROCE %	7.12
	Years of Profitability over Past 10-Year	5
	Moat Score	4
	Tariff Resilience Score	6

GF Value Rank

9/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	38.6
	Forward PE Ratio	21.31
	PE Ratio without NRI	38.6
	Price-to-Owner-Earnings	16.75
	PS Ratio	3.28
	PB Ratio	2.01
	Price-to-Free-Cash-Flow	15.33
	Price-to-Operating-Cash-Flow	12.76
	EV-to-EBIT	22.66
	EV-to-EBITDA	14.71
	EV-to-Revenue	3.78
	EV-to-FCF	17.67
	Price-to-GF-Value	0.85
	Price-to-Projected-FCF	1.76
	Earnings Yield (Greenblatt) %	4.41
	FCF Yield %	6.5
	Forward Rate of Return (Yacktman) %	-22.26

GF Value™: $3.26

VIMGF

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with VIMGF. Try a 7-Day Free Trial to check it out.

Vimian Group AB Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Vimian Group AB Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings conference call for 2026	2026-10-22	In 116 days
Third quarter earnings results for 2026	2026-10-22	In 116 days
Second quarter earnings conference call for 2026	2026-07-17	In 19 days
Second quarter earnings results for 2026	2026-07-17	In 19 days
General meeting for 2026	2026-04-29 14:30	2.77 (+0.00%)
First quarter earnings conference call for 2026	2026-04-29	2.77 (+0.00%)
First quarter earnings results for 2026	2026-04-29	2.77 (+0.00%)
Annual report for 2025	2026-03-19	2.77 (+0.00%)
Fourth quarter earnings conference call for 2025	2026-02-12 09:00	2.77 (+0.00%)
Fourth quarter earnings results for 2025	2026-02-12 07:45	2.77 (+0.00%)

Show

Entries

Guru Commentaries on OTCPK:VIMGF

No articles.

Press Release

	Subject	Date
No Press Release

Articles on Vimian Group AB

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.